Vapotherm’s Precision Flow Hi-VNI system, which is clinically proven to treat both Type 1 (hypoxic) and Type II (hypercapnic) respiratory distress, is the only HFNC product listed under the United ...
Vapotherm Inc. (VAPO) is a medical technology company that primarily focuses on developing and monetizing its Hi-VNI technology. It leverages its proprietary Precision Flow system via four different ...
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that ...